Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target, Yielding 19.01% Profit: QuantWave's Success

May 03, 2023
ELI LILLY AND COMPANY stock recently reached the forecasted price target set by QuantWave, resulting in a profitable outcome for investors. The forecast signal was issued on December 14, 2022, with the stock price at 356.27 $. The predicted direction was long, and on May 3, 2023, the stock reached the target price of 423.98 $, delivering a profit of 19.01%.

This success can be attributed to various factors, including positive market sentiment towards the pharmaceutical company, strong financial performance, and overall industry trends. Investors who followed QuantWave's forecast and took action accordingly were able to capitalize on this opportunity.

QuantWave's automated forecasting platform continues to provide valuable insights for traders and investors looking to make informed decisions in the stock market. With a track record of accurate predictions, QuantWave offers users the chance to explore forecasts for a wide range of stocks, presenting potential opportunities for profitable trades.

For those seeking a deeper understanding of QuantWave's investment strategy, QuantSchool offers educational resources that outline the essential principles for generating consistent income using the QuantWave forecasting system. By leveraging QuantWave's analytics and following a structured approach to investing, individuals can enhance their chances of achieving success in the financial markets.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

PFEFebruary 16, 2025Pfizer Inc. NYSE:PFE is gaining popularity among institutional owners  ~2 min.

Pfizer Inc., a leading pharmaceutical company, is currently being favored by institutional owners, with 68% of the company being held by them....

ENBAugust 19, 2024ENBRIDGE INC. Hits Price Target Forecast on QuantWave Platform, Yielding 11.56% Profit  ~1 min.

ENBRIDGE INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.56%. The forecast signal was initiated on December 26, 2023, at a price of 34.55 $....

NVOApril 4, 2025NOVO NORDISK A/S Hits Short Price Target with 29.84% Profit: QuantWave Forecast Success  ~1 min.

On February 24, 2025, QuantWave made a short forecast signal for NOVO NORDISK A/S stock when it was priced at 89.15 $....

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 18.25% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved to be highly accurate, as the stock reached the predicted target price of 1172.09 $ on August 15, 2024, from the signal price of 991....

PPLApril 3, 2025PPL CORPORATION Stock Hits Price Target Forecast with 17.87% Profit  ~1 min.

On August 20, 2024, QuantWave issued a price target forecast for PPL CORPORATION stock at $30.49 with a predicted long direction....